CONTRI, CHIARA
 Distribuzione geografica
Continente #
AS - Asia 1.003
NA - Nord America 950
EU - Europa 593
SA - Sud America 189
AF - Africa 70
OC - Oceania 23
Totale 2.828
Nazione #
US - Stati Uniti d'America 887
SG - Singapore 319
IT - Italia 282
CN - Cina 174
BR - Brasile 125
VN - Vietnam 119
HK - Hong Kong 84
FR - Francia 67
BD - Bangladesh 63
GB - Regno Unito 55
DE - Germania 50
JP - Giappone 49
CA - Canada 40
IN - India 38
EG - Egitto 34
CO - Colombia 29
CH - Svizzera 21
ID - Indonesia 20
NL - Olanda 20
RU - Federazione Russa 18
AR - Argentina 17
ZA - Sudafrica 17
IR - Iran 14
MX - Messico 14
TR - Turchia 14
NZ - Nuova Zelanda 13
IL - Israele 12
IQ - Iraq 11
PK - Pakistan 11
AU - Australia 10
ES - Italia 10
KR - Corea 10
KZ - Kazakistan 9
BE - Belgio 8
IE - Irlanda 8
PH - Filippine 8
PL - Polonia 8
FI - Finlandia 7
SA - Arabia Saudita 7
TW - Taiwan 7
UZ - Uzbekistan 7
EC - Ecuador 6
MY - Malesia 6
AT - Austria 5
KE - Kenya 5
MA - Marocco 5
SE - Svezia 5
RS - Serbia 4
UA - Ucraina 4
GR - Grecia 3
JO - Giordania 3
KW - Kuwait 3
NG - Nigeria 3
PE - Perù 3
PS - Palestinian Territory 3
PY - Paraguay 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BO - Bolivia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
LT - Lituania 2
PA - Panama 2
PT - Portogallo 2
RO - Romania 2
TH - Thailandia 2
VE - Venezuela 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
HU - Ungheria 1
JM - Giamaica 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 2.828
Città #
Singapore 202
Ashburn 182
San Jose 116
Hong Kong 80
Beijing 49
New York 47
Los Angeles 42
Council Bluffs 40
Santa Clara 40
Tokyo 36
Ho Chi Minh City 33
Cairo 29
Hanoi 29
Meridian 28
Ferrara 25
Albosaggia 24
Milan 22
Munich 20
Naples 19
Jakarta 18
Lauterbourg 18
Bogotá 17
São Paulo 16
Montreal 15
Shanghai 15
Denver 14
Zurich 14
Chennai 12
Rome 12
Chandler 11
Dallas 11
Hefei 11
Toronto 11
Buffalo 10
Da Nang 10
Manchester 9
Orem 9
Tannowa 9
Tucson 9
Almaty 8
Brooklyn 8
Galway 8
Medellín 8
Ankara 7
Bologna 7
Chicago 7
Johannesburg 7
Malonne 7
Warsaw 7
Bari 6
Campinas 6
Haiphong 6
Livorno 6
Louisville 6
Tashkent 6
Venice 6
Atlanta 5
Azusa 5
Baghdad 5
Boston 5
Chattanooga 5
Christchurch 5
Dresden 5
Dunedin 5
Frankfurt am Main 5
Geneva 5
Madrid 5
Parma 5
Rio de Janeiro 5
Tel Aviv 5
Auburn 4
Charlotte 4
Curitiba 4
Falkenstein 4
Florence 4
London 4
Melbourne 4
Moscow 4
Nairobi 4
Nashville 4
Phoenix 4
Pisa 4
Poplar 4
Redondo Beach 4
Salt Lake City 4
San Diego 4
Taranto 4
The Dalles 4
Vienna 4
Athens 3
Auckland 3
Belo Horizonte 3
Blumenau 3
Boardman 3
Brisbane 3
Bristol 3
Can Tho 3
Cuauhtémoc 3
Fairfield 3
Helsinki 3
Totale 1.609
Nome #
Pharmacological characterization of new modulators of the endocannabinoid system: from single target to multi-target compounds 766
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions 157
Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target? 157
Adenosine and inflammation: Here, there and everywhere 152
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets 144
Pharmacology of Adenosine Receptors: Recent Advancements 132
Synthesis of Unsymmetrical Squaramides as Allosteric GSK-3β Inhibitors Promoting β-Catenin-Mediated Transcription of TCF/LEF in Retinal Pigment Epithelial Cells 131
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies 127
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients 123
Targeting Relevant HDACs to Support the Survival of Cone Photoreceptors in Inherited Retinal Diseases: Identification of a Potent Pharmacological Tool with In Vitro and In Vivo Efficacy 117
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence 116
Pioneering first-in-class FAAH-HDAC inhibitors as potential multitarget neuroprotective agents 116
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition 113
Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications 111
Cytotoxic and Antiproliferative Effects of [64Cu]CuCl2 in Tumor Cells for Radiometabolic Therapy: a Preliminary Study 106
Reversing TGF-β1-induced fibrotic phenotype in human lung fibroblasts using a PROTAC tool derived from an indoline-based HDAC6 inhibitor 92
Cytotoxic and Antiproliferative Effects of [64Cu]CuCl2 in Tumor Cells for Radiometabolic Therapy: a Preliminary Study. 91
Uncovering a Mutation-Independent Therapeutic Strategy against Inherited Retinal Diseases: Development of Class I HDAC/LSD1 Hybrid Inhibitors 58
Cytotoxic and Antiproliferative Effects of [64Cu]CuCl2 in Tumor Cells for Radiometabolic Therapy 46
New Vanillyl-capped HDAC inhibitors exhibit anti-tumor efficacy in neuroblastoma and glioblastoma cells 35
Totale 2.890
Categoria #
all - tutte 10.444
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.444


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202218 0 0 0 0 0 0 0 7 0 0 8 3
2022/202331 3 5 0 3 2 3 6 2 3 0 3 1
2023/2024203 5 3 4 1 20 0 3 3 4 58 43 59
2024/2025752 42 52 53 39 58 74 49 53 111 68 82 71
2025/20261.886 180 72 153 178 254 127 179 136 159 240 168 40
Totale 2.890